Smartleaf Asset Management LLC Apellis Pharmaceuticals, Inc. Transaction History
Smartleaf Asset Management LLC
- $610 Billion
- Q2 2024
A detailed history of Smartleaf Asset Management LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 56 shares of APLS stock, worth $2,200. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56
Previous 8
600.0%
Holding current value
$2,200
Previous $502,000
363.15%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding APLS
# of Institutions
299Shares Held
113MCall Options Held
5.21MPut Options Held
691K-
Wellington Management Group LLP Boston, MA16.4MShares$644 Million0.11% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$456 Million15.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$437 Million5.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$385 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$228 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $4.32B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...